Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Short-Term Debt issuances (2019 - 2022)

Historic Short-Term Debt issuances for United Therapeutics (UTHR) over the last 3 years, with Q1 2022 value amounting to $800.0 million.

  • United Therapeutics' Short-Term Debt issuances changed N/A to $800.0 million in Q1 2022 from the same period last year, while for Dec 2022 it was $800.0 million, marking a year-over-year change of. This contributed to the annual value of $800.0 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that United Therapeutics reported Short-Term Debt issuances of $800.0 million as of Q1 2022.
  • United Therapeutics' 5-year Short-Term Debt issuances high stood at $800.0 million for Q1 2019, and its period low was $800.0 million during Q1 2019.